Rekombinanter IL4R (Dupilumab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter IL4R (Dupilumab Biosimilar) Antikörper (ABIN7488008)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Applikation
Güteklasse
-
-
Expressionssystem
- Mammalian cells
-
Verwendungszweck
- Dupilumab Biosimilar - Anti-IL4R, CD124 mAb
-
Produktmerkmale
- Antibody Type: IgG4-kappa
-
Aufreinigung
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotyp
- IgG4 kappa
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS pH 7.5
-
Lagerung
- -80 °C
-
Informationen zur Lagerung
- store at -80°C
-
-
- IL4R (Dupilumab Biosimilar)
-
Substanzklasse
- Biosimilar
-
Hintergrund
-
CD124,REGN668,SAR231893
Dupilumab is a human monoclonal antibody of isotype IgG4 that targets the interleukin-4 (IL-4) receptor, inhibiting the receptor signaling pathways. Dupilumab inhibits the signaling pathway of interleukins, that induce inflammatory and immunological reactions in several atopic or allergic conditions, such as eczema, allergic reaction, and rhinosinusitis. -
CAS-Nummer
- 1190264-60-8
Target
-